Appointment of UBS Limited as Joint Broker

RNS Number : 1868B

Hutchison China Meditech Limited

15 February 2011

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Appointment of UBS Limited as Joint Broker

London: Tuesday, 15 February 2011: Chi-Med today announces that it has appointed UBS Limited as its joint broker effective on 14 February 2011.  Panmure Gordon (UK) Limited will continue to act as a broker of Chi-Med.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone] Mobile: [phone] Mobile: [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone: [phone]
UBS Limited Adrian Haxby Neil Patel	Telephone: [phone]
Panmure Gordon (UK) Limited Richard Gray Rakesh Sharma	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

APPDKQDPDBKDABD